Cor Vasa 2009, 51(7-8):478-480 | DOI: 10.33678/cor.2009.121

Pulmonary hypertension and chronic heart failure

Hikmet Al-Hiti*, Vojtěch Melenovský, Jiří Kettner, Ivan Málek, Josef Kautzner, Marek Hrnčárek
Klinika kardiologie, Institut klinické a experimentální medicíny, Centrum pro diagnostiku a léčbu plicní hypertenze, Praha, Česká republika

The number of patients with chronic heart failure is on the rise thanks to the comprehensive treatment of acute coronary syndromes and episodes of acute heart failure. These patients often have pulmonary hypertension adversely affecting their prognosis. Some cases require testing of the pulmonary vascular bed reactivity prior to a cardiac surgical procedure. The aim of this paper is to provide the reader with an insight into the issue of pulmonary hypertension in chronic heart failure, with a focus on novel therapies potentially modulating pulmonary hypertension.

Keywords: Chronic heart failure; Pulmonary hypertension; Drug therapy

Published: July 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Al-Hiti H, Melenovský V, Kettner J, Málek I, Kautzner J, Hrnčárek M. Pulmonary hypertension and chronic heart failure. Cor Vasa. 2009;51(7-8):478-480. doi: 10.33678/cor.2009.121.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Simonneau G, Galie N, Rubin L, et al. Clinical classification of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:5S-12S. Go to original source... Go to PubMed...
    2. Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exercise intolerance in patient with heart failure. J Am Coll Cardiol 1999;34: 1802-6. Go to original source...
    3. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary. Artury pressure in patients with chronic heart failure. J Am Coll Cardiol 2001; 37:183-8. Go to original source...
    4. von Scheidr W, Costard-Kaeckle A, Stempfle HU, et al. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the Prophet study. J Heart Lung Transplant 2006;25: 1070-6. Go to original source... Go to PubMed...
    5. Klotz S, Wenzelburger F, Stypmann J, et al. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant. Ann Thorac Surg 2006;82:1770-3. Go to original source... Go to PubMed...
    6. Gavazzi A, Ohio S, Scelsi L, et al. Response of right ventricle to acute pulmonary vasodilatation predicts the outcome in patiens with advanced heart failure and pulmonary hypertension. Am Heart J 2003;145:310-6. Go to original source... Go to PubMed...
    7. Givertz MM, Hare JM, Loh E, et al. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patiens with severe left vetricular dysfunction: a rapid test for reversibility of pulmonary hypertension. J Am Coll Cardiol 1996;28:1775-80. Go to original source... Go to PubMed...
    8. Loh E, Stamler JS, Hare JM, et al. Cardiovascular effects of inhaled nitric oxide in patiens with left ventricular dysfunction. Circulation 1994;90: 2780-5. Go to original source... Go to PubMed...
    9. Zimpfer D, Zrunek P, Sander S, et al. Post transplant survival after lowering fixed pulmonary hypertension using left ventricular assist device. Eur J Cardiothorac Surg 2007;31:698-702. Go to original source... Go to PubMed...
    10. Lepore JJ, Maroo A, Bigatello LM, et al. Hemodynamic effects of sildenafil in patiens with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest 2005;127: 1647-53. Go to original source... Go to PubMed...
    11. Califf RM, Adams KF, McKenna WJ, at al. A randomized controlled trial of epoprostenol therapy for sever congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J 1997;134:44-54. Go to original source... Go to PubMed...
    12. Kelland NF, Webb DJ. Clinical trials of endothelin antagonists in heart failure: publication is good for the public health. Heart 2007;93:2-4. Go to original source... Go to PubMed...
    13. Nand I, McMurray J, John JN, et al. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blined, placebo-controlled trial. Lancet 2004;364:347-54. Go to original source... Go to PubMed...
    14. Lewis GD, Shahzad K, Causo L, et al. Sildenafil therapy for systolic heart failure with secondary pulmonary hypertension: a randomized double-blinded, placebo-controlled study (Abstract). J Card Fail 2006;12 (Suppl 1):S70. Go to original source...
    15. Al-Hiti H, Melenovsky V, Kettner J, et al. Sildenafil is more selective pulmonary vasodilatator than PGE 1 in patiens with severe pulmonary hypertension secondary to heart failure (Abstract). Chest 2008;134:32001. Go to original source...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes